Research Article
Seven-Signal Proteomic Signature for Detection of Operable Pancreatic Ductal Adenocarcinoma and Their Discrimination from Autoimmune Pancreatitis
Table 1
Discrimination of samples in the training cohort according to 7-signal proteomic model.
| | Number of cases analyzed | Number of correctly assigned cases (%) | 95% C.I.* (%) |
| All samples | 160 | 134 (83.8) | 77.1–89.1 | Pancreatic ductal adenocarcinoma | 80 | 61 (76.3) | 65.4–85.1 | Healthy subjects | 80 | 73 (91.3) | 82.8–96.4 | age | | | | ≤60 | 43 | 30 (69.8) | 53.9–82.8 | >60 | 37 | 31 (83.8) | 68.0–93.8 | Clinical stage of pancreatic ductal adenocarcinoma patients | | | | 0/I | 3 | 3 (100) | 29.2–100 | II | 8 | 5 (62.5) | 24.5–91.5 | III | 8 | 8 (100) | 63.1–100 | IVa | 14 | 10 (71.4) | 41.9–91.6 | IVb | 47 | 35 (74.5) | 59.7–86.1 |
|
|
*95% confidence interval.
|